Australia’s Pharmako Biotechnologies is launching its first liposomal technology which could be used to increase the bioavailability of nutraceuticals containing nutrients that are hydrophilic and lipophilic in nature.
Australia-based Pharmako Biotechnologies is planning several new studies following the recent announcement of its Therapeutic Goods Administration (TGA)-approved manufacturing site, which allows it to produce pharma grade ingredients for use in clinical...